Skip to main content

Advertisement

SpringerLink
Log in

Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies

  • Toxicology Observation
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Introduction

Synthetic cannabinoid receptor agonists (SCRAs) are emerging designer drugs of abuse. Most reports on the health effects of these drugs are case reports. Unlike SCRAs, marijuana has classically been used via many routes of exposure including oral, such as in brownies. We report on 11 symptomatic patients who unknowingly ingested brownies laced with analytically confirmed SCRA and presented with mostly neuropsychiatric and cardiovascular symptoms.

Case Series

All 11 patients were taken to the ED within 1 h of exposure with the onset of various symptoms. There were five males and six females, age range 20–57 years. Neuropsychiatric and cardiovascular symptoms predominated: memory impairment (91 %, 10/11) and inappropriate giggling (36 %, 4/11). All the patients had light-headedness, perioral and facial numbness and tingling sensation, dry mouth, difficulty focusing/blurring of vision, and sluggishness. No patient had depressed consciousness. Two patients had heart rates >100, and 4 of 11 (36 %) had BP >140/80. One patient had chest pain. All the symptoms were completely resolved 4 h following their onset except two patients who had ongoing weakness and fatigue. All patients had negative urine drugs of abuse immunoassays and ethanol, acetaminophen, and salicylate concentrations, as well as normal electrocardiograms (ECGS) and metabolic panels. The SCRA was confirmed to be AM-2201. All the patients were discharged from the ED in stable condition within 10 h of the exposure.

Conclusion

Oral exposure of 11 patients to brownies laced with analytically confirmed SCRA resulted in neuropsychiatric and cardiovascular symptoms. This series reflects that like marijuana, oral exposures to SCRAs can lead to symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brent LK, Prather PL. The K2/Spice phenomenon: emergence, identification, legislation and characterization of synthetic cannabinoids in herbal incense products. Drug Metab Rev. 2014;46(1):72–85.

    Article  Google Scholar 

  2. Sobolevsky T, Prosolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post administration urine. Forensic Sci Int. 2010;200:141–7.

    Article  CAS  PubMed  Google Scholar 

  3. Spaderma M, Addy PH, D’Souza DC. Spicing thing up: synthetic cannabinoids. Psychopharmacology (Berl). 2013;228(4):525–40.

    Article  Google Scholar 

  4. Barrat MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev. 2013;32(2):141–6.

    Article  Google Scholar 

  5. McQuade D, Hudson S, Dargan PI, Wood DM. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. Eur J Clin Pharmacol. 2013;69:373–6.

    Article  PubMed  Google Scholar 

  6. Uchiyama N, Kikura-Hanjiri R, Ogata J, Goda Y. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int. 2010;198(1–3):31–8.

    Article  CAS  PubMed  Google Scholar 

  7. European Monitoring Center for Drugs and Drug Addiction E. Thematic paper. Understanding the “Spice” phenomenon. Office for official Publications, Lisbon. 2009. http://www.emcdda.europa.eu/publications.

  8. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoid: epidemiology pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144(v):12–41.

    Article  CAS  PubMed  Google Scholar 

  9. Gundeson EW, Haughey HM, Ait Daoud N, Joshi AS, Hart CL. A survey of synthetic cannabinoid consumption current cannabis users. Subst Abus. 2014;35(2):184–9.

    Article  Google Scholar 

  10. Food and Drug Administration Safety and Innovation Act. United States. 2012. http://www.fda.gov/regulatoryInformation/legislation/federalFoodDrugandCosmeticAct.

  11. Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid exposures reported to Texas poison centers. J Addict Dis. 2011;30(4):351–8.

    Article  PubMed  Google Scholar 

  12. Musselman ME, Hampton JP. “Not for human consumption”: a review of emerging designer drugs. Pharmacotherapy. 2014;34(7):745–57.

    Article  PubMed  Google Scholar 

  13. Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid and marijuana reported to poison centers. Hum Exp Toxicol. 2012;31(10):1006–11.

    Article  CAS  PubMed  Google Scholar 

  14. Monte A, Bronstein A, Heard K, Iwanicki J. An outbreak of exposure to a novel synthetic cannabinoid. NEJM. 2013;37:389–90.

    Google Scholar 

  15. Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128(6):e1622–7.

    Article  PubMed  Google Scholar 

  16. Young AC, Schwarz E, Medina G, Obafemi A, Feng SY, Kane C, et al. Cardiotoxicity associated with the synthetic cannabinoid, K9 with laboratory confirmation. Am J Emerg Med. 2012;30(7):1320.

    Article  PubMed  Google Scholar 

  17. Cone EJ, Johnson RE, Paul BD, Mell LD, Mitchell J. Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in human following ingestion. J Anal Toxicol. 1988;12(4):169–75.

    Article  CAS  PubMed  Google Scholar 

  18. Centers for Disease control and Prevention (CDC). Inadvertent ingestion of marijuana—Los Angeles, California, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(34):947–50.

    Google Scholar 

  19. Heath TS, Burroughs Z, Thompson AJ, Tecklenburg FW. Acute intoxication caused by a synthetic cannabinoid in two adolescents. J Pediatr Pharmacol Ther. 2012;17(2):177–81.

    PubMed Central  PubMed  Google Scholar 

  20. Meijer KA, Russo RR, Adhvaryu DV. Smoking synthetic marijuana leads to self- mutilation requiring bilateral amputations. Orthopedics. 2014;37(4):e391–4.

    Article  PubMed  Google Scholar 

  21. Aoun EG, Chritopher PP, Ingraham JW. Emerging drugs of abuse: clinical and legal considerations. R I Med J. 2013;96(6):41–5.

    Google Scholar 

  22. Drug Enforcement Administration DJ. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into schedule 1. Fed Regist. 2014;79:1776–80.

    Google Scholar 

  23. Auwarter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N. ‘Spice’ and other herbal blend: harmless incense or cannabinoid designer drugs? J Mass Spectrom. 2009;44(5):832–7.

    Article  PubMed  Google Scholar 

  24. Hu X, Primack BA, Barnett TE, Cook RL. College students and use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy. 2011;5:16.

    Article  Google Scholar 

  25. Heishman SJ, Huetis MA, Henningfield JE. Acute and residual effect of marijuana: profiles of plasma THC levels, physiological, subjective and performance measures. Pharmacol Biochem Behav. 1990;37:561–7.

    Article  CAS  PubMed  Google Scholar 

  26. Dewane WA, Breuer A, Sheskin T, Jarbe TU, Eisen MS, Mechoulam R. A novel probe for the cannabinoid receptor. J Med Chem. 1992;35(11):2065–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UT Southwestern Medical Center, Dallas, TX, USA

    Adebisi I. Obafemi, Kurt Kleinschmidt & Collin Goto

  2. Texas Department of Public Safety, Garland, TX, USA

    Drew Fout

Authors
  1. Adebisi I. Obafemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurt Kleinschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Collin Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Drew Fout
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adebisi I. Obafemi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Obafemi, A.I., Kleinschmidt, K., Goto, C. et al. Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies. J. Med. Toxicol. 11, 426–429 (2015). https://doi.org/10.1007/s13181-015-0482-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-015-0482-z

Keywords

Search

Navigation